Exact Mass: 404.9928

Exact Mass Matches: 404.9928

Found 26 metabolites which its exact mass value is equals to given mass value 404.9928, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Strongarm

Diclosulam

C13H10Cl2FN5O3S (404.9865)


CONFIDENCE standard compound; INTERNAL_ID 590; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8213; ORIGINAL_PRECURSOR_SCAN_NO 8211 CONFIDENCE standard compound; INTERNAL_ID 590; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8254; ORIGINAL_PRECURSOR_SCAN_NO 8252 CONFIDENCE standard compound; INTERNAL_ID 590; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8212; ORIGINAL_PRECURSOR_SCAN_NO 8210 CONFIDENCE standard compound; INTERNAL_ID 590; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4063; ORIGINAL_PRECURSOR_SCAN_NO 4059 CONFIDENCE standard compound; INTERNAL_ID 590; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8174; ORIGINAL_PRECURSOR_SCAN_NO 8172 CONFIDENCE standard compound; INTERNAL_ID 590; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4075; ORIGINAL_PRECURSOR_SCAN_NO 4072 CONFIDENCE standard compound; INTERNAL_ID 590; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8263; ORIGINAL_PRECURSOR_SCAN_NO 8260 CONFIDENCE standard compound; INTERNAL_ID 590; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8267; ORIGINAL_PRECURSOR_SCAN_NO 8264 CONFIDENCE standard compound; INTERNAL_ID 590; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4074; ORIGINAL_PRECURSOR_SCAN_NO 4072 CONFIDENCE standard compound; INTERNAL_ID 590; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4058; ORIGINAL_PRECURSOR_SCAN_NO 4055 CONFIDENCE standard compound; INTERNAL_ID 590; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4071; ORIGINAL_PRECURSOR_SCAN_NO 4070 CONFIDENCE standard compound; INTERNAL_ID 590; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4041; ORIGINAL_PRECURSOR_SCAN_NO 4039

   

Ceftizoxime Sodium

Ceftizoxime Sodium

C13H12N5NaO5S2 (405.0178)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-2-thiophenesulfonamide

N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-2-thiophenesulfonamide

C13H9F6NO3S2 (404.9928)


   
   
   

3,5-Dibromo-4-[3-(dimethylamino)propoxy]cinnamic acid

3,5-Dibromo-4-[3-(dimethylamino)propoxy]cinnamic acid

C14H17Br2NO3 (404.9575)


   

5-Azacytidine 5-diphosphate

5-Azacytidine 5-diphosphate

C8H13N3O12P2 (404.9974)


   

6-chloro-3-[(4-fluorophenyl)methyl]-1,1-dioxo-3,4-dihydro-2H-1λ6,2,4-benzothiadiazine-7-sulfonamide

6-chloro-3-[(4-fluorophenyl)methyl]-1,1-dioxo-3,4-dihydro-2H-1λ6,2,4-benzothiadiazine-7-sulfonamide

C14H13ClFN3O4S2 (405.002)


   

Copolymerofacrylicacidand2-Acrylamido-2-MethylpropylSulfonicAcid

Copolymerofacrylicacidand2-Acrylamido-2-MethylpropylSulfonicAcid

C10H17NNa2O9S2 (405.014)


   

disodium 4-(acetylamino)-5-hydroxynaphthalene-2,7-disulphonate

disodium 4-(acetylamino)-5-hydroxynaphthalene-2,7-disulphonate

C12H9NNa2O8S2 (404.9565)


   

1-Ethyl-2,3-Dimethylimidazolium Bis(Trifluoromethanesulfonyl)Imide

1-Ethyl-2,3-Dimethylimidazolium Bis(Trifluoromethanesulfonyl)Imide

C9H13F6N3O4S2 (405.0252)


   

1-Propyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide

1-Propyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide

C9H13F6N3O4S2 (405.0252)


   

4-iodo-1-(toluene-4-sulfonyl)-1H-pyrrole-2-carboxylic acid Methyl ester

4-iodo-1-(toluene-4-sulfonyl)-1H-pyrrole-2-carboxylic acid Methyl ester

C13H12INO4S (404.9532)


   

N6-Methyladenosine 5-Monophosphate Sodium Salt

N6-Methyladenosine 5-Monophosphate Sodium Salt

C11H14N5Na2O7P (405.0426)


N6-Methyladenosine 5'-monophosphate disodium salt is an activator of glycogen phosphorylase b, with a Ka value of 22 μM[1]. N6-Methyladenosine 5'-monophosphate disodium salt is a non-competitive rat adenylate kinase II inhibitor[2].

   

3-Iodo-5-[4-(4-morpholinyl)phenyl]-1H-pyrrolo[2,3-b]pyridine

3-Iodo-5-[4-(4-morpholinyl)phenyl]-1H-pyrrolo[2,3-b]pyridine

C17H16IN3O (405.0338)


   

TRIFLUORO-METHANESULFONIC ACID 2-BENZYLOXY-4-FORMYL-6-NITRO-PHENYL ESTER

TRIFLUORO-METHANESULFONIC ACID 2-BENZYLOXY-4-FORMYL-6-NITRO-PHENYL ESTER

C15H10F3NO7S (405.013)


   

N-(4-bromo-9,10-dihydro-9,10-dioxo-1-anthryl)benzamide

N-(4-bromo-9,10-dihydro-9,10-dioxo-1-anthryl)benzamide

C21H12BrNO3 (405.0001)


   

3-iodo-4-methyl-N-[3-(trifluoromethyl)phenyl]benzamide

3-iodo-4-methyl-N-[3-(trifluoromethyl)phenyl]benzamide

C15H11F3INO (404.9837)


   

DICHLORO(DIMETHYLGLYOXIMATO)(DIMETHYLGLYOXIME)RHODIUM(III)

DICHLORO(DIMETHYLGLYOXIMATO)(DIMETHYLGLYOXIME)RHODIUM(III)

C8H16Cl2N4O4Rh (404.9604)


   

tert-butyl N-(5-bromo-2-chlorophenyl)-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate

tert-butyl N-(5-bromo-2-chlorophenyl)-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate

C16H21BrClNO4 (405.0342)


   

Garcinia cambogia extract

Garcinia cambogia extract

C16H21BrClNO4 (405.0342)


   

SDZ 220-581 (hydrochloride)

SDZ 220-581 (hydrochloride)

C16H18Cl2NO5P (405.03)


SDZ 220-581 hydrochloride is an orally active, potent, competitive NMDA receptor antagonist with pKi value of 7.7[1].

   

Copper usnate

Copper usnate

C18H14CuO7 (405.0035)


G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids

   

6-Azauridine diphosphate

6-Azauridine diphosphate

C8H13N3O12P2 (404.9974)


   

HIF-2α-IN-1

HIF-2α-IN-1

C16H8F5NO4S (405.0094)


HIF-2α-IN-1 is a HIF-2α inhibitor with an IC50 value of less than 500 nM.